KELLI KIRBY: Open Payments
NPI 1518521244 · HUEYTOWN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,798 in 63 payments from 18 companies in 2025. Trend: 2023 $1,165 · 2024 $1,514 · 2025 $2,798
Food & beverage: $2,798
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $697 |
| Novo Nordisk Inc | 11 | $548 |
| Amgen Inc. | 4 | $296 |
| Axsome Therapeutics, Inc. | 4 | $291 |
| ABBVIE INC. | 11 | $193 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $86 |
Products named: Auvelity, AIRSUPRA, Ozempic, BREZTRI, FARXIGA, VRAYLAR, REPATHA, Wegovy.
Industry payments across AL — which companies pay providers there.
